New French Proteomics Firm Launches | GenomeWeb Daily News ...
The technology was developed by researchers at the Exploring the Dynamics of Proteomes laboratory and was described in a 2007 interview with Brun by GenomeWeb Daily News The University of Pennsylvania's Hakon Hakonarson and his colleagues describe... NEW YORK (GenomeWeb News) – Promise Advanced Proteomics, a French fee-for-service proteomics firm providing mass spectrometry-based absolute quantification services, has launched. The company officially launched late last month, said Virginie Brun, the company's co-founder and chief scientific officer who was part of a team that developed the company's technology. Based in Grenoble, France, Promise is a spinout of the Exploring the Dynamics of Proteomes laboratory at the National Institute of Health and Medical Research, the French Atomic Energy and Alternative Energies Commission, and Université Joseph... ANNOVAR can be run on a desktop computer, the team reports, and takes only four minutes to perform gene-based annotation and 15 to perform variants reduction on 4. Specifically, it employs a technology called Protein Standard Absolute Quantification for developing full-length isotopically-labeled proteins. The proteins can be used for quantitative proteomics and analytical research. DeCode Genetics' Kari Stefansson and his colleagues show an association between common variants near CAV1 and CAV2 and primary open-angle glaucoma. Promise provides services for the development of therapeutic proteins and biomarkers. GenomeQuest said this week that CEO Ron Ranauro has resigned and will be replaced by Richard Resnick as acting CEO. "The risk variant identified here is located close to CAV1 and CAV2, both of which are expressed in the trabecular meshwork and retinal ganglion cells that are involved in the pathogenesis of POAG," the authors write. In their genome-wide association study, the DeCode-led team gentoypes 1,263 affected individuals and 34,877 controls from Iceland. He formerly was CEO of Mosaic Bioinformatics , and he was global bioinformatics software head at Wyeth. 7 million variants, "making it practical to handle hundreds of human genomes in a day....



Investment Firm to Buy 49 Percent Stake in Olink:
read more